Meningococcal Vaccination

Pronounced (muh-nin-jeh-KOK-ul)

Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. There are 2 types of meningococcal vaccines available in the United States:

  • Meningococcal conjugate or MenACWY vaccines (Menactra® and Menveo®)
  • Serogroup B meningococcal or MenB vaccines (Bexsero® and Trumenba®)

All 11 to 12 year olds should get a meningococcal conjugate vaccine, with a booster dose at 16 years old. Teens and young adults (16 through 23 year olds) also may get a serogroup B meningococcal vaccine. CDC also recommends meningococcal vaccination for other children and adults who are at increased risk for meningococcal disease.

Talk with your or your child’s clinician if you have questions about meningococcal vaccines.

CDC recommends routine meningococcal conjugate vaccination for:

  • All preteens and teens at 11 to 12 years old with a booster dose at 16 years old
  • Children and adults at increased risk for meningococcal disease

CDC recommends routine serogroup B meningococcal vaccination for

  • People 10 years or older at increased risk for meningococcal disease

Page last reviewed: July 26, 2019